Fewer patients receive recommendations for pharmacotherapy in primary prevention using the 2018 atherosclerotic cardiovascular disease risk estimator.

Campos-Staffico, Alessandra M; Cordwin, David; Ding, Yuting; Lester, Corey A; Brook, Robert D; Luzum, Jasmine A; Dorsch, Michael P

Fewer patients receive recommendations for pharmacotherapy in primary prevention using the 2018 atherosclerotic cardiovascular disease risk estimator.

Campos-Staffico, Alessandra M; Cordwin, David; Ding, Yuting; Lester, Corey A; Brook, Robert D; Luzum, Jasmine A; Dorsch, Michael P.

Afiliación

Campos-Staffico AM; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Cordwin D; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Ding Y; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Lester CA; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Brook RD; Division of Cardiovascular Medicine, Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Luzum JA; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.
Dorsch MP; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: mdorsch@med.umich.edu.

Prev Med ; 148: 106555, 2021 07.

Article en En | MEDLINE | ID: mdl-33862035

Asunto(s)

Aterosclerosis; Enfermedades Cardiovasculares; Inhibidores de Hidroximetilglutaril-CoA Reductasas; Adulto; Anciano; Aterosclerosis/tratamiento farmacológico; Aterosclerosis/prevención & control; Enfermedades Cardiovasculares/tratamiento farmacológico; Enfermedades Cardiovasculares/prevención & control; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; Persona de Mediana Edad; Prevención Primaria; Estudios Retrospectivos; Medición de Riesgo; Factores de Riesgo

Palabras clave

Atherosclerotic disease; Primary prevention; Risk assessment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Prev Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google